市場調査レポート

商品コード

1561058

CRISPR技術の市場規模、シェア、成長分析、製品タイプ別、用途別、地域別 - 産業予測、2024年～2031年

CRISPR Technology Market Size, Share, Growth Analysis, By Product Type (Products, Services), By Application (Biomedical, Industrial), By Application (Pharma & Biopharma Companies, Biotechnology Companies), By Region - Industry Forecast 2024-2031

出版日: 2024年09月22日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

CRISPR技術の世界市場規模は、2022年に30億米ドルと評価され、2023年の35億米ドルから2031年には118億6,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは16.50％で成長する見通しです。

世界のCRISPR技術市場は、バイオテクノロジーの中で急速に発展している有望な分野です。CRISPRはClustered Regularly Interspaced Short Palindromic Repeatsの略で、生物のDNAに正確な改変を加えることができる画期的な遺伝子編集ツールです。この革新的な技術は、遺伝子疾患への対応、治療法開発の進歩、農業慣行の変革の可能性があることから、大きな関心を集めています。CRISPR市場は顕著な成長を遂げており、近い将来も拡大が続くと予測されています。この成長には、個別化医療に対する需要の高まり、遺伝子治療の進歩、遺伝性疾患の有病率の増加など、いくつかの要因が寄与しています。CRISPR技術の創薬、市場開拓、診断ツール作成への統合は、市場拡大をさらに加速させています。さらに、産業バイオテクノロジー分野では、CRISPRをバイオエンジニアリングやバイオ製造に活用することで、従来の製造方法に代わる持続可能な新しい酵素、バイオ燃料、特殊化学品の創出を可能にしています。全体として、CRISPR技術市場は急速に進化しており、ヘルスケア、農業、産業バイオテクノロジーなど様々な分野に革命を起こす可能性を秘めています。その応用は、人間の健康を増進し、食品生産を改善し、持続可能な製造方法を進歩させる可能性を秘めています。研究開発が進むにつれ、CRISPR技術の責任ある有益な使用を確実にするためには、倫理的および規制上の懸念への対処が不可欠となります。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Thermo Fisher Scientific Inc.（US）
Merck KGaA（Germany）
Integrated DNA Technologies（Danaher Corporation）（US）
Agilent Technologies Inc.（US）
Genscript Biotech Corp（China）
New England Biolabs Inc.（US）
Cellecta Limited（US）
GeneCopoeia Inc.（US）
Origene Technologies Inc.（US）
Editas Medicine, Inc.（US）
CRISPR Therapeutics AG（Switzerland）
Intellia Therapeutics, Inc.（US）
Illumina, Inc.（US）
Base Genomics Inc.（US）
Synthego Corporation（US）
Prime Medicine, Inc.（US）
Arbor Biotechnologies（US）
Excision BioTherapeutics, Inc.（US）
Mammoth Biosciences, Inc.（US）

Product Code: SQMIG35H2108

Global CRISPR Technology Market size was valued at USD 3.0 billion in 2022 and is poised to grow from USD 3.50 billion in 2023 to USD 11.86 billion by 2031, growing at a CAGR of 16.50% during the forecast period (2024-2031).

The global CRISPR technology market is a rapidly developing and promising area within biotechnology. CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, represents a revolutionary gene-editing tool that enables precise alterations to the DNA of living organisms. This innovative technology has captured significant interest due to its potential to address genetic disorders, drive advancements in therapeutic development, and transform agricultural practices. The CRISPR market has experienced notable growth and is projected to continue expanding in the near future. Several factors contribute to this growth, including the rising demand for personalized medicine, progress in gene therapy, and the increasing prevalence of genetic disorders. The integration of CRISPR technology into drug discovery, development, and diagnostic tool creation has further accelerated market expansion. Additionally, the industrial biotechnology sector is utilizing CRISPR for bioengineering and bio-manufacturing, enabling the creation of novel enzymes, biofuels, and specialty chemicals that offer sustainable alternatives to conventional manufacturing methods. Overall, the CRISPR technology market is evolving rapidly with the potential to revolutionize various fields, including healthcare, agriculture, and industrial biotechnology. Its applications hold promise for enhancing human health, improving food production, and advancing sustainable manufacturing practices. As research and development continue to progress, addressing ethical and regulatory concerns will be essential to ensure the responsible and beneficial use of CRISPR technology moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global CRISPR Technology Market Segmental Analysis

Global CRISPR Technology Market is segmented by Product Type, Application, and region. Based on Product Type, the market is segmented into Products [CRISPR Libraries, CRISPR Kits & Enzymes, Other Products], Services [Cell Line Engineering, gRNA Design & Vector Consultation, Screening Services, Other Services]. Based on Application, the market is segmented into Biomedical, Industrial, Agricultural, and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global CRISPR Technology Market

Governments worldwide have significantly ramped up their funding and investment in CRISPR technology, creating a supportive environment for research and development. This increased financial backing has facilitated groundbreaking discoveries and accelerated advancements in the field, fostering a dynamic market for CRISPR innovations. As a result, the enhanced investment in CRISPR technology has led to a more vibrant and promising sector, driving progress and expanding opportunities within biotechnology. This support from government bodies is crucial for advancing research efforts and bringing transformative CRISPR-based solutions to fruition.

Restraints in the Global CRISPR Technology Market

The gene editing field faces significant technical challenges associated with CRISPR technology. Despite its considerable potential, several hurdles impede its broader application, including the complexity of achieving precise genome modifications, managing off-target effects, and ensuring effective delivery mechanisms. Addressing these technical issues is crucial for CRISPR technology to fulfill its transformative potential across various industries. Overcoming these obstacles will be key to unlocking the full benefits of CRISPR and advancing its use in a wide range of applications.

Market Trends of the Global CRISPR Technology Market

A notable trend in the CRISPR technology market is the growing integration of CRISPR in drug discovery and development. Pharmaceutical and biotechnology companies are increasingly leveraging CRISPR to streamline the drug discovery process, enhance target identification and validation, and improve both preclinical and clinical studies. CRISPR-based screening platforms facilitate more efficient identification and validation of drug targets, which contributes to the development of more effective therapies. Furthermore, CRISPR enables the creation of advanced disease models and organoids, aiding in the study of disease mechanisms and the evaluation of potential drug candidates. In addition to its impact on drug discovery, CRISPR technology is also making strides in agriculture and food production, as well as in the development of CRISPR-based diagnostics. The emphasis on ethical and regulatory considerations is also growing, reflecting a broader awareness of the implications of CRISPR technology. These trends underscore the expanding potential of CRISPR across multiple industries, highlighting its transformative capabilities and the ongoing evolution of its applications.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

CRISPR Technology Market by Product Type

Market Overview
Products
- CRISPR Libraries
- CRISPR Kits & Enzymes
- Other Products
Services
- Cell Line Engineering
- gRNA Design & Vector Consultation
- Screening Services
- Other Services

CRISPR Technology Market by Application

Market Overview
Biomedical
Industrial
Agricultural
Other Applications

CRISPR Technology Market by End-User

Market Overview
Pharma & Biopharma Companies
Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations

CRISPR Technology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies (Danaher Corporation) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corp (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellecta Limited (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneCopoeia Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origene Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Editas Medicine, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRISPR Therapeutics AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intellia Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Base Genomics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthego Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prime Medicine, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arbor Biotechnologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Excision BioTherapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mammoth Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

CRISPR技術の市場規模、シェア、成長分析、製品タイプ別、用途別、地域別 - 産業予測、2024年～2031年

CRISPR Technology Market Size, Share, Growth Analysis, By Product Type (Products, Services), By Application (Biomedical, Industrial), By Application (Pharma & Biopharma Companies, Biotechnology Companies), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

CRISPR技術市場：製品タイプ別

CRISPR技術市場：用途別

CRISPR技術市場：エンドユーザー別

CRISPR技術市場規模：地域別